News from astellas pharma europe ltd A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

20 Nov, 2014, 09:00 GMT Astellas Opens New Regional Affiliate Office for Middle East, North and Sub-Saharan Africa in Dubai

Astellas Pharma Europe Ltd., has announced the opening of a new regional office in Dubai to support the company's growing business operations in the...


23 May, 2014, 00:01 BST Astellas Announces Groundbreaking €1.5m Programme to Tackle Obstetric Fistula in Kenya

Funding will help treat 1,200 women with life-changing surgery and support major outreach project Astellas Pharma Europe Ltd. (APEL), the European...


14 May, 2014, 00:01 BST New Data Shows DIFICLIR™ (fidaxomicin) Reduces Recurrence and Provides Cost Savings When Used First-Line for Clostridium Difficile Infection

Recurrence has been identified by The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) as the most important problem in the ...


12 May, 2014, 07:00 BST EUCLID Study Reveals More Than 39,000 Cases of Clostridium Difficile Infection May Be Missed Each Year

Clostridium difficile is the major cause of infective, hospital-acquired diarrhoea in the developed world[1] The full set of data from EUCLID, the...


02 May, 2014, 18:06 BST En ECCMID 2014 se presentan los resultados del principal estudio sobre infección por Clostridium difficile

- Los primeros resultados completos del mayor estudio de prevalencia de la UE sobre infección por Clostridium difficile se presentarán en ECCMID 2014 ...


30 Apr, 2014, 07:00 BST Largest EU Prevalence Study of Clostridium Difficile Infection First Full Results to be Presented at ECCMID 2014

A high abundance of data from the EUCLID study is to be presented at ECCMID this year on Clostridium difficile infection (CDI), one of the most...


17 Mar, 2014, 11:32 GMT First Patients Enrolled into European Phase III Programme for Potential First in Class Oral Treatment for Anaemia Associated with Chronic Kidney Disease (CKD)

Roxadustat could change treatment of anaemia associated with CKD and remove the need for multiple injections Astellas Pharma Europe Ltd. today...


03 Dec, 2013, 15:47 GMT World-renowned Scientists Discuss Whether Scientific Innovation Can Turn Old Age into a New Age

Lord Robert Winston chaired THE ASTELLAS INNOVATION DEBATE 2013 The Age Crunch - facts, fears and the future Royal Institution of Great Britain, held ...


19 Nov, 2013, 16:09 GMT Nobel Laureate, Dr. Elizabeth H.Blackburn Joins Panel of The Astellas Innovation Debate 2013

The Age Crunch - facts, fears and the future Chaired by Lord Robert Winston Royal Institution of Great Britain, Tuesday 19th November 2013, 7pm To be ...


15 Nov, 2013, 17:59 GMT Medical Oncologist Professor Tim Eisen Joins Panel of THE ASTELLAS INNOVATION DEBATE 2013

The Age Crunch - facts, fears and the future Chaired by Lord Robert Winston Royal Institution of Great Britain, Tuesday 19th November 2013, 7pm To be ...


15 Nov, 2013, 15:15 GMT Politician, Broadcaster and Journalist, Baroness Joan Bakewell Joins Panel of the Astellas Innovation Debate 2013

 The Age Crunch - facts, fears and the future Chaired by Lord Robert Winston Royal Institution of Great Britain, Tuesday 19th November 2013, 7pm To...


15 Nov, 2013, 15:15 GMT Nobel Laureate, Dr. Elizabeth H. Blackburn joins panel of THE ASTELLAS INNOVATION DEBATE 2013

The Age Crunch - facts, fears and the future Chaired by Lord Robert Winston Royal Institution of Great Britain, Tuesday 19th November 2013, 7pm To be ...


07 Nov, 2013, 07:00 GMT Baroness Sally Greengross, Chief Executive of the International Longevity Centre - UK, joins panel of THE INNOVATION DEBATE 2013

The Age Crunch - facts, fears and the future Chaired by Lord Robert Winston Royal Institution of Great Britain, Tuesday 19th November 2013, 7pm To be ...


07 Nov, 2013, 07:00 GMT Professor John Appleby, Chief Economist at the King's Fund, joins panel of THE ASTELLAS INNOVATION DEBATE 2013

The Age Crunch - facts, fears and the future Chaired by Lord Robert Winston Royal Institution of Great Britain, Tuesday 19th November 2013, 7pm To be ...


07 Nov, 2013, 07:00 GMT Can Scientific Innovation Turn Old Age into A New Age?

Lord Robert Winston to chair THE ASTELLAS INNOVATION DEBATE 2013 The Age Crunch - facts, fears and the future Royal Institution of Great Britain,...


07 Nov, 2013, 07:00 GMT Professor Tom Kirkwood of Newcastle University's Institute for Ageing and Health

joins panel of THE ASTELLAS INNOVATION DEBATE 2013 The Age Crunch - facts, fears and the future Chaired by Lord Robert Winston Royal Institution of...


29 Oct, 2013, 08:00 GMT New Guidelines Recommend Fidaxomicin for All Patients Who Are Suitable for Oral Antibiotic Treatment for Clostridium Difficile Infection

Clostridium difficile infection (CDI), a potentially fatal disease, has surpassed MRSA as the leading cause of healthcare-acquired infections in...


09 Sep, 2013, 07:00 BST New Data Provides Insights into the Prophylaxis of Organ Rejection and Prophylaxis of Fungal Infections in Liver Transplant Patients

In liver transplant patients, late renal failure is a significant cause of morbidity and is associated with premature mortality[1],[2],[3] Invasive...


22 Jul, 2013, 08:00 BST German Federal Joint Committee Recognises "Proof of a Considerable Additional Benefit" For DIFICLIR™ for the Treatment of Clostridium difficile Infection

 Clostridium difficile infection (CDI), a potentially fatal disease, is one of the most common healthcare acquired infections[1] Astellas Pharma...


27 Apr, 2013, 01:01 BST Largest EU Prevalence Study of Clostridium Difficile Infection Reveals That More Than One Fifth of Patients May Receive Wrong Diagnosis

Clostridium difficile infection (CDI), a potentially fatal disease, is one of the most common healthcare acquired infections[1], at least twice as...


19 Apr, 2013, 11:00 BST New Expert Report Informs Europe's Policymakers on Crucial Changes Needed to Improve the Diagnosis and Management of CDI

Clostridium difficile infection (CDI), a potentially fatal disease, is one of the most common healthcare-associated infections[1] Urgent action is...


14 Mar, 2013, 09:00 GMT European Commission Approves New Pre-treatment Options for QUTENZA™ (8% Capsaicin Patch) in Peripheral Neuropathic Pain

- For Healthcare and Business Media - Approval allows for more flexible approach to 8% capsaicin patch treatment of peripheral neuropathic pain The...


11 Jan, 2013, 08:30 GMT New Class of Treatment for Overactive Bladder Approved in Europe

A new treatment, BETMIGA[TM] (mirabegron) has received approval from the European Commission (EC) for the treatment of overactive bladder (OAB)...


03 Dec, 2012, 08:00 GMT Largest Ever Study of Clostridium Difficile Infection to Attempt to Reveal True Incidence Of Disease

Clostridium difficile infection (CDI), a potentially fatal disease, is one of the most common healthcare acquired infections[1] Today marks the...


06 Nov, 2012, 15:07 GMT Astellas Relocates European HQ and UK Operations to Accommodate new Growth

Spectacular New Facilities, in Chertsey, Designed by Sir Norman Foster Astellas Pharma Europe Ltd. (APEL), the European Headquarters of Tokyo-based...